This Article Full Text Full Text (PDF) All Versions of this Article: 18/8/1906    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blanquart, C. Articles by Glineur, C. Search for Related Content PubMed PubMed Citation Articles by Blanquart, C. Articles by Glineur, C.

The Protein Kinase C Signaling Pathway Regulates a Molecular Switch between Transactivation and Transrepression Activity of the Peroxisome Proliferator-Activated Receptor

Institut National de la Santé et de la Recherche Médicale, Unité de Recherche 545, Département d’Athérosclérose, Institut Pasteur de Lille, 59019 Lille, and Faculté de Pharmacie, Université de Lille II, 59000 Lille, France

Address all correspondence and requests for reprints to: Dr. Corine Glineur, UR 545 Institut National de la Santé et de la Recherche Médicale, Département d’Athérosclérose, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019 Lille, France. E-mail: Corine.Glineur{at}pasteur-lille.fr.

Peroxisome proliferator-activated receptor (PPAR) is a nuclear receptor implicated in several physiological processes such as lipid and lipoprotein metabolism, glucose homeostasis, and the inflammatory response. PPAR is activated by natural fatty acids and synthetic compounds like fibrates. PPAR activity has been shown to be modulated by its phosphorylation status. PPAR is phosphorylated by kinases such as the MAPKs and cAMP-activated protein kinase A. In this report, we show that protein kinase C (PKC) inhibition impairs ligand-activated PPAR transcriptional activity. Furthermore, PKC inhibition decreases PPAR ligand-induction of its target genes including PPAR itself and carnitine palmitoyltransferase I. By contrast, PKC inhibition enhances PPAR transrepression properties as demonstrated using the fibrinogen-ß gene as model system. Finally, PKC inhibition decreases PPAR phosphorylation activity of hepatocyte cell extracts. In addition, PPAR purified protein is phosphorylated in vitro by recombinant PKC and ßII. The replacement of serines 179 and 230 by alanine residues reduces the phosphorylation of the PPAR protein. The PPAR S179A-S230A protein displays an impaired ligand-induced transactivation activity and an enhanced trans-repression activity. Altogether, our data indicate that the PKC signaling pathway acts as a molec-ular switch dissociating the transactivation and transrepression functions of PPAR, which involved phosphorylation of serines 179 and 230.

NURSA Molecule Pages Link:

Nuclear Receptors:   PPARα

Ligands:   GW 7647

This article has been cited by other articles:

				R. Gineste, A. Sirvent, R. Paumelle, S. Helleboid, A. Aquilina, R. Darteil, D. W. Hum, J.-C. Fruchart, and B. Staels Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity Mol. Endocrinol., November 1, 2008; 22(11): 2433 - 2447. [Abstract] [Full Text] [PDF]

				L. Qiu, X. Wu, J. F. L. Chau, I. Y. Y. Szeto, W. Y. Tam, Z. Guo, S. K. Chung, P. J. Oates, S. S. M. Chung, and J. Y. Yang Aldose Reductase Regulates Hepatic Peroxisome Proliferator-activated Receptor {alpha} Phosphorylation and Activity to Impact Lipid Homeostasis J. Biol. Chem., June 20, 2008; 283(25): 17175 - 17183. [Abstract] [Full Text] [PDF]

				K. Sun, V. Montana, K. Chellappa, Y. Brelivet, D. Moras, Y. Maeda, V. Parpura, B. M. Paschal, and F. M. Sladek Phosphorylation of a Conserved Serine in the Deoxyribonucleic Acid Binding Domain of Nuclear Receptors Alters Intracellular Localization Mol. Endocrinol., June 1, 2007; 21(6): 1297 - 1311. [Abstract] [Full Text] [PDF]

				R. Paumelle and B. Staels Peroxisome Proliferator-Activated Receptors Mediate Pleiotropic Actions of Statins Circ. Res., May 25, 2007; 100(10): 1394 - 1395. [Full Text] [PDF]

				M. A. Yakubu, R. H. Nsaif, and A. O. Oyekan Peroxisome Proliferator-Activated Receptor {alpha} Activation-Mediated Regulation of Endothelin-1 Production via Nitric Oxide and Protein Kinase C Signaling Pathways in Piglet Cerebral Microvascular Endothelial Cell Culture J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 774 - 781. [Abstract] [Full Text] [PDF]

				R. Paumelle, C. Blanquart, O. Briand, O. Barbier, C. Duhem, G. Woerly, F. Percevault, J.-C. Fruchart, D. Dombrowicz, C. Glineur, et al. Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator-Activated Receptor-{alpha} via Inhibition of the Protein Kinase C Signaling Pathway Circ. Res., February 17, 2006; 98(3): 361 - 369. [Abstract] [Full Text] [PDF]